Seeyond Abiomed Inc Transaction History

Seeyond

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$242.49 - $301.46 $50,680 - $63,005	-209 Reduced 5.1%	3,887 $954,000
Q2 2022 Aug 12, 2022	SELL	$224.73 - $338.64 $348,556 - $525,230	-1,551 Reduced 27.47%	4,096 $1.01 Million
Q1 2022 May 13, 2022	BUY	$277.25 - $366.29 $440,550 - $582,034	1,589 Added 39.16%	5,647 $1.87 Million
Q4 2021 Feb 14, 2022	SELL	$300.63 - $371.35 $897,079 - $1.11 Million	-2,984 Reduced 42.37%	4,058 $1.46 Million
Q3 2021 Nov 12, 2021	SELL	$310.19 - $376.2 $22,023 - $26,710	-71 Reduced 1.0%	7,042 $2.29 Million
Q2 2021 Aug 13, 2021	BUY	$262.71 - $351.17 $8,144 - $10,886	31 Added 0.44%	7,113 $2.22 Million
Q1 2021 May 14, 2021	SELL	$285.92 - $355.13 $368,550 - $457,762	-1,289 Reduced 15.4%	7,082 $2.26 Million
Q4 2020 Feb 12, 2021	BUY	$251.88 - $324.2 $310,568 - $399,738	1,233 Added 17.27%	8,371 $2.71 Million
Q3 2020 Nov 12, 2020	BUY	$255.22 - $317.0 $786,843 - $977,311	3,083 Added 76.03%	7,138 $1.98 Million
Q2 2020 Aug 13, 2020	BUY	$141.4 - $257.09 $486,698 - $884,903	3,442 Added 561.5%	4,055 $980,000
Q1 2020 May 14, 2020	SELL	$130.51 - $196.01 $391 - $588	-3 Reduced 0.49%	613 $4.35 Million
Q3 2019 Nov 13, 2019	BUY	$175.89 - $279.23 $48,721 - $77,346	277 Added 81.71%	616 $110,000
Q2 2019 Aug 13, 2019	SELL	$250.96 - $284.94 $18,320 - $20,800	-73 Reduced 17.72%	339 $88,000
Q4 2018 Feb 14, 2019	BUY	$281.08 - $444.25 $115,804 - $183,031	412 New	412 $134,000

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of Seeyond, based on Form 13F filings with the SEC.

Stay updated on Seeyond with notifications on news.